Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

7.1K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

10.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.3K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

1.8K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunopathophysiology of immune checkpoint inhibitor-related pneumonitis: insights from multi-omics and immune profiling.

Immunological medicine·2026
Same author

Real-world effectiveness, safety and patient-reported outcomes of sarilumab in patients with rheumatoid arthritis: a 52-week, prospective, open-label, non-interventional, observational, nationwide, large-cohort study in Japan (PROFILE-J).

RMD open·2026
Same author

Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation.

Cancer immunology research·2026
Same author

Distinct fibrosis-associated macrophage subsets coordinate iron metabolism in pulmonary fibrosis.

International immunology·2026
Same author

Impact of pre-existing interstitial lung abnormalities on pneumonitis risk and survival in chemo-naive patients with non-small-cell lung cancer receiving pembrolizumab plus chemotherapy.

Respiratory medicine·2026
Same author

Subset binding enables detection of multimodal patient subgroup patterns and drug target discovery in idiopathic pulmonary fibrosis.

Briefings in bioinformatics·2026

Related Experiment Video

Updated: May 6, 2026

RNA Interference-based Investigation of the Function of Heat Shock Protein 27 during Corneal Epithelial Wound Healing
08:34

RNA Interference-based Investigation of the Function of Heat Shock Protein 27 during Corneal Epithelial Wound Healing

Published on: September 27, 2016

6.7K

Osteoprotection by semaphorin 3A.

Mikihito Hayashi1, Tomoki Nakashima, Masahiko Taniguchi

  • 1Department of Cell Signaling, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Yushima 1-5-45, Bunkyo-ku, Tokyo 113-8549, Japan.

Nature
|April 24, 2012
PubMed
Summary
This summary is machine-generated.

Semaphorin 3A (Sema3A) protects bone by inhibiting osteoclast activity and promoting osteoblast formation. This dual action, mediated by binding to neuropilin-1 (Nrp1), offers a potential therapeutic strategy for bone diseases.

More Related Videos

Analysis of Retinoic Acid-induced Neural Differentiation of Mouse Embryonic Stem Cells in Two and Three-dimensional Embryoid Bodies
09:04

Analysis of Retinoic Acid-induced Neural Differentiation of Mouse Embryonic Stem Cells in Two and Three-dimensional Embryoid Bodies

Published on: April 22, 2017

8.6K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

8.9K

Related Experiment Videos

Last Updated: May 6, 2026

RNA Interference-based Investigation of the Function of Heat Shock Protein 27 during Corneal Epithelial Wound Healing
08:34

RNA Interference-based Investigation of the Function of Heat Shock Protein 27 during Corneal Epithelial Wound Healing

Published on: September 27, 2016

6.7K
Analysis of Retinoic Acid-induced Neural Differentiation of Mouse Embryonic Stem Cells in Two and Three-dimensional Embryoid Bodies
09:04

Analysis of Retinoic Acid-induced Neural Differentiation of Mouse Embryonic Stem Cells in Two and Three-dimensional Embryoid Bodies

Published on: April 22, 2017

8.6K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

8.9K

Area of Science:

  • Bone Biology and Skeletal Homeostasis
  • Cell Signaling and Molecular Mechanisms
  • Therapeutic Development for Bone Diseases

Background:

  • Bone mass is regulated by local factors influencing osteoblasts and osteoclasts, alongside systemic hormones.
  • Osteoprotegerin inhibits osteoclast activity but no single local factor was known to regulate both osteoblasts and osteoclasts.
  • Identifying local regulators of bone mass is crucial for understanding and treating skeletal disorders.

Purpose of the Study:

  • To investigate the role of semaphorin 3A (Sema3A) as a local determinant of bone mass.
  • To elucidate the molecular mechanisms by which Sema3A influences osteoclast and osteoblast activity.
  • To evaluate the therapeutic potential of Sema3A in bone regeneration and disease.

Main Methods:

  • Investigated Sema3A's effect on osteoclast differentiation by analyzing receptor activator of nuclear factor-κB ligand (RANKL)-induced pathways.
  • Examined Sema3A and neuropilin-1 (Nrp1) binding's impact on osteoblast and adipocyte differentiation via Wnt/β-catenin signaling.
  • Utilized Sema3a knockout mice and genetically modified Nrp1 mice to assess in vivo bone phenotypes.
  • Administered intravenous Sema3A in mice to evaluate bone volume and regeneration capacity.

Main Results:

  • Sema3A binding to Nrp1 suppressed RANKL-induced osteoclast differentiation by inhibiting immunoreceptor tyrosine-based activation motif (ITAM) and RhoA signaling.
  • Sema3A/Nrp1 signaling stimulated osteoblast differentiation and inhibited adipocyte differentiation through the canonical Wnt/β-catenin pathway.
  • Sema3a deficiency or disruption of the Sema3A-binding site on Nrp1 led to an osteopenic phenotype.
  • Intravenous Sema3A administration increased bone volume and accelerated bone regeneration in mice.

Conclusions:

  • Semaphorin 3A (Sema3A) is a novel local factor that exerts osteoprotective effects by simultaneously suppressing osteoclastic bone resorption and enhancing osteoblastic bone formation.
  • The interaction between Sema3A and its receptor Nrp1 modulates key signaling pathways (ITAM, RhoA, Wnt/β-catenin) critical for bone cell differentiation and function.
  • Sema3A demonstrates significant potential as a therapeutic agent for treating bone and joint diseases, including osteoporosis and fracture healing.